PNMA6A
Paraneoplastic antigen-like protein 6A
Also known as: MGC15827, PNM6A_HUMAN, PNMA6C
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P0CW24
- Gene
- PNMA6A
- Ensembl
- ENSG00000235961
- Chromosome
- X
- Canonical length
- 399 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
No narrative summary is available for PNMA6A in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
399 residues, UniProt reviewed canonical sequence.
>P0CW24|PNMA6A
1 MAVTMLQDWC RWMGVNARRG LLILGIPEDC DDAEFQESLE AALRPMGHFT VLGKAFREED
61 NATAALVELD REVNYALVPR EIPGTGGPWN VVFVPRCSGE EFLGLGRVFH FPEQEGQMVE
121 SVAGALGVGL RRVCWLRSIG QAVQPWVEAV RCQSLGVFSG RDQPAPGEES FEVWLDHTTE
181 MLHVWQGVSE RERRRRLLEG LRGTALQLVH ALLAENPART AQDCLAALAQ VFGDNESQAT
241 IRVKCLTAQQ QSGERLSAFV LRLEVLLQKA MEKEALARAS ADRVRLRQML TRAHLTEPLD
301 EALRKLRMAG RSPSFLEMLG LVRESEAWEA SLARSVRAQT QEGAGARAGA QAVARASTKV
361 EAVPGGPGRE PEGLLQAGGQ EAEELLQEGL KPVLEECDNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PNMA6A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 39 nTPM
- hypothalamus: 27 nTPM
- amygdala: 19 nTPM
- cerebellum: 18 nTPM
- hippocampal formation: 16 nTPM
- basal ganglia: 15 nTPM
Single-cell type
- epididymal principal cells: 55 nCPM
- retinal amacrine cells: 35 nCPM
- epididymal efferent duct absorptive cells: 25 nCPM
- tuft cells: 23 nCPM
- other brain neurons: 19 nCPM
- respiratory ionocytes: 18 nCPM
Immune cell
- eosinophil: 2 nTPM
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 54 nTPM
- basal ganglia: 34 nTPM
- hypothalamus: 34 nTPM
- white matter: 33 nTPM
- pons: 32 nTPM
- thalamus: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
InteractionsUniProt · HPA
Protein binding partners of PNMA6A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PNMA6A as an antibody target. Whether an autoantibody or antibody against PNMA6A could matter depends on whether native PNMA6A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PNMA6A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PNMA6A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...